XenoTherapeutics

Paul is the co-founder and CEO of Mercy Bioanalytic. He began his career in 1986 as an investment banker with Citibank and Donaldson, Lufkin & Jenrette. He then served as the Presi...

Profi - Wellness Support

Our novel family of Janus base nanomaterials is based on DNA nanotechnology.

A next-generation biosecurity platform, by Ginkgo Bioworks.

Clinical-stage rare disease biopharmaceutical company developing novel therapeutics for treatment of abnormal mineralization diseases. We are focused on therapies to treat the rare...

At Cora Care, we are developing prognostic tools to help pet owners take care of their pets.

Innovating to transform the treatment of devastating diseases through intracellular therapeutics.

Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating insights from genetic epilepsies into the development of therapies for central nervous system, ...

NanoView Biosciences is focused on enabling worldwide life science researchers to better understand the biological role of extracellular vesicles, including exosomes and viral vect...

Welcome to Pronova, we are here to help you care for your pets by pioneering a new standard of care.

Alexion, AstraZeneca Rare Disease was created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. by AstraZeneca. For more than 30 years, Alexion’s mission has been to ...